610 related articles for article (PubMed ID: 31693057)
1. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
[TBL] [Abstract][Full Text] [Related]
2. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
[TBL] [Abstract][Full Text] [Related]
4. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
Olivotto I; Maron BJ; Tomberli B; Appelbaum E; Salton C; Haas TS; Gibson CM; Nistri S; Servettini E; Chan RH; Udelson JE; Lesser JR; Cecchi F; Manning WJ; Maron MS
J Am Coll Cardiol; 2013 Jul; 62(5):449-57. PubMed ID: 23643593
[TBL] [Abstract][Full Text] [Related]
5. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
[TBL] [Abstract][Full Text] [Related]
6. Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Hypertrophic Cardiomyopathy.
Goldstein SA; Kennedy KF; Friedman DJ; Al-Khatib SM; Wang A
J Am Heart Assoc; 2023 Aug; 12(16):e029293. PubMed ID: 37586066
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events.
Maurizi N; Passantino S; Spaziani G; Girolami F; Arretini A; Targetti M; Pollini I; Tomberli A; Pradella S; Calabri GB; Vinattieri V; Bertaccini B; Leone O; De Simone L; Rapezzi C; Marchionni N; Cecchi F; Favilli S; Olivotto I
JAMA Cardiol; 2018 Jun; 3(6):520-525. PubMed ID: 29710196
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
Choi YJ; Kim HK; Hwang IC; Park CS; Rhee TM; Lee HJ; Park JB; Yoon YE; Lee SP; Cho GY; Kim YJ
Heart; 2023 Apr; 109(10):771-778. PubMed ID: 36581445
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.
Ziółkowska L; Turska-Kmieć A; Petryka J; Kawalec W
Pediatr Cardiol; 2016 Mar; 37(3):448-58. PubMed ID: 26526335
[TBL] [Abstract][Full Text] [Related]
12. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices.
Shirani J; Aurshiya R; Elshaikh A; Olenchock SA; Rowin EJ; Maron MS; Maron BJ
Am J Cardiol; 2021 Mar; 142():130-135. PubMed ID: 33279482
[TBL] [Abstract][Full Text] [Related]
13. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
[TBL] [Abstract][Full Text] [Related]
14. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
Conway J; Min S; Villa C; Weintraub RG; Nakano S; Godown J; Tatangelo M; Armstrong K; Richmond M; Kaufman B; Lal AK; Balaji S; Power A; Baez Hernandez N; Gardin L; Kantor PF; Parent JJ; Aziz PF; Jefferies JL; Dragulescu A; Jeewa A; Benson L; Russell MW; Whitehill R; Rossano J; Howard T; Mital S
Circulation; 2023 Feb; 147(9):718-727. PubMed ID: 36335467
[TBL] [Abstract][Full Text] [Related]
15. Effects of sex on clinical outcomes of hypertrophic cardiomyopathy in Singapore.
Li TY; Yeo S; Ngiam NJ; Lee CH; Low TT; Lim YC; Evangelista LKM; Lee EC; Sari NY; Yeo TC; Yip JW; Poh KK; Kong WK; Lin W; Sia CH; Wong RC
Ann Acad Med Singap; 2023 Jul; 52(7):348-355. PubMed ID: 38904500
[TBL] [Abstract][Full Text] [Related]
16. Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.
Nomura A; Konno T; Fujita T; Tanaka Y; Nagata Y; Tsuda T; Hodatsu A; Sakata K; Nakamura H; Kawashiri MA; Fujino N; Yamagishi M; Hayashi K
Circ J; 2015; 79(1):136-43. PubMed ID: 25381793
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study.
Wang Y; Gao W; Han X; Jiang J; Sandler B; Li X; Zema C
J Med Econ; 2023; 26(1):1495-1506. PubMed ID: 37902966
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography.
Masri A; Pierson LM; Smedira NG; Agarwal S; Lytle BW; Naji P; Thamilarasan M; Lever HM; Cho LS; Desai MY
Am Heart J; 2015 May; 169(5):684-692.e1. PubMed ID: 25965716
[TBL] [Abstract][Full Text] [Related]
19. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
Yazaki K; Suzuki A; Shiga T; Minami Y; Arai K; Ashihara K; Shoda M; Hagiwara N
BMC Cardiovasc Disord; 2021 Feb; 21(1):106. PubMed ID: 33607967
[TBL] [Abstract][Full Text] [Related]
20. Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Maron MS; Rastegar H; Dolan N; Carpino P; Koethe B; Maron BJ; Rowin EJ
Am J Cardiol; 2022 Jan; 163():91-97. PubMed ID: 34785034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
